CHEK2 and chronic myelogenous leukemia, BCR-ABL1 positive: The absence of p-ATM and the predominant absence of p-CHK2 in the PBMCs of de novo CP-CML and BP-CML patients might be explained by missing or minor expression of ATM and CHK2, respectively.